Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autopsy Follow-up of Florbetapir F 18 PET
NCT01447719Phase 3Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of florbetapir (18F) in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Mar 2010; status: completed.
02
Drugs
florbetapir (18F)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01447719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447719.